Novilase® Breast Therapy

    

BENIGN BREAST TUMORS

Breast tumors, whether benign or malignant, pose significant health concerns for women today. Early detection of these lesions remains the most effective weapon in combating this issue.

Among the distinct types of solid breast tumors, fibroadenomas are the most prevalent, affecting approximately 10% of women. When women discover these tumors during self-examination or through a routine mammogram, many opt for surgical excision of the fibroadenoma after consulting with their doctors.

ABLATE REGISTRY – BENIGN BREAST TUMOR TREATMENT

The ABLATE registry aimed to assess the effectiveness and safety of Novilase for treating benign breast tumors (≤20 mm) by gathering real-world evidence.

Novian Health has obtained FDA 510(k) clearance to treat benign breast tumor lesions and perform soft tissue ablation. To support the establishment of a reimbursement code, they initiated the ABLATE registry, aiming to gather relevant real-world data. The registry enrolled 100 women across eight sites in the USA.

For more information, see: www.clinicaltrial.gov ( #NCT00807924 )

Why choose Novilase?

Novilase has received FDA 510(k) clearance for treating benign breast lesions and conducting soft tissue ablation. Specifically designed as a minimally invasive option for benign breast tumors and an alternative to lumpectomy or vacuum-assisted biopsy, Novilase offers several significant advantages over lumpectomy:

  • It is less invasive than traditional surgery.
  • The procedure is performed using local anesthesia, reducing the need for general anesthesia.
  • There is minimal scarring, as the procedure only requires a bandage for closure, avoiding using sutures.
  • The risks associated with surgery and surgical complications may be significantly reduced.
  • Recovery time is quicker, with patients often able to resume normal activities within hours rather than days.
  • The procedure can be performed in an outpatient setting
  • Typically, a 20 mm benign tumor can be effectively treated in a 15-minute laser procedure.

For a referral, contact info@novianhealth.com

TELL A FRIEND

If someone you know, whether a friend or family member, has been recently diagnosed with a benign tumor, you can inform them about Novilase by emailing this link.

Back to top